CAJ | 학술논문

目的：分析我国现行基本药物目录遴选情况，发现问题并探讨改进方法，为下一步基本药物遴选工作提供建议。方法分析整理国家目录和省级增补目录制定中的相关文件，针对研究主题开展专家访谈，对部分省份进行重点调研，归纳国家和省级基本药物目录增补数量和增补流程，讨论其中存在的问题和对策。结果国家目录制定和各省增补程序大致相同，但在遴选范围、推荐机构及其他相关细节上有所不同，有些省份增补药品次数频繁。总体上看，无论国家还是省级，在增补过程中均缺乏科学的遴选依据，过于依赖主观意见，增补方法和流程有待完善。结论当前，基本药物目录进入微调阶段，应考虑引入药物经济学及循证医学评价，增加评价参与者，将整个遴选流程规范化、透明化。
목적：분석아국현행기본약물목록린선정황，발현문제병탐토개진방법，위하일보기본약물린선공작제공건의。방법분석정리국가목록화성급증보목록제정중적상관문건，침대연구주제개전전가방담，대부분성빈진행중점조연，귀납국가화성급기본약물목록증보수량화증보류정，토론기중존재적문제화대책。결과국가목록제정화각성증보정서대치상동，단재린선범위、추천궤구급기타상관세절상유소불동，유사성빈증보약품차수빈번。총체상간，무론국가환시성급，재증보과정중균결핍과학적린선의거，과우의뢰주관의견，증보방법화류정유대완선。결론당전，기본약물목록진입미조계단，응고필인입약물경제학급순증의학평개，증가평개삼여자，장정개린선류정규범화、투명화。
Objective To analyze the selection of National Essential Drug List (EDL)and Provincial Additional List,find the problems and discuss the updated methods in order to offer advices for the further selection of Essential Drug List. Methods Collecting and analyzing the relevant documents, carrying out expert interviews and conducting the survey in some provinces to summarize the number and process of EDL selection at national and provincial level. The existing problems and solution were discussed.Results The processes of National EDL selection and Provincial EDL supplement were similar, with some differences in such details as the selection scope and referrers, and some provinces supplemented the Provincial Additional List much too frequently. In general, at both national and provincial levels,there were very few scientific grounds in the selection process,and the method and process should be updated and optimized.Conclusion Currently,the EDL entered the stage of fine-tuning, during which pharmaco-economics and evidence-based evaluation should be applied. More participants should be engaged in the discussion and evaluation in order to make the selection process more standardized and transparent.